First experience with (224)Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)

BACKGROUND: Peritoneal metastasis (PM) from colorectal cancer carries a dismal prognosis despite extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). With a median time to recurrence of 11–12 months, there is a need for novel therapies. Radspherin® consists of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Stein Gunnar, Graf, Wilhelm, Mariathasan, Anthony Burton, Sørensen, Olaf, Spasojevic, Milan, Goscinski, Mariusz Adam, Selboe, Silje, Lundstrøm, Nadja, Holtermann, Anne, Revheim, Mona-Elisabeth, Bruland, Øyvind Sverre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016379/
https://www.ncbi.nlm.nih.gov/pubmed/36936230
http://dx.doi.org/10.3389/fmed.2023.1070362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016379/
https://www.ncbi.nlm.nih.gov/pubmed/36936230
http://dx.doi.org/10.3389/fmed.2023.1070362

Ejemplares similares